A Single-center, Randomized, Active-controlled, Parallel-group, Open-label, Phase I Study to Evaluate Safety and Immunogenicity of Single Injection of LBVD or Eupenta Co-administered With Imovax Polio in Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 16 Apr 2018
At a glance
- Drugs DTP-HepB-IPV-Hib vaccine LG Chem (Primary) ; Hib-DTP-hepatitis B vaccine; Poliovirus vaccine inactivated
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
- Focus Adverse reactions
- Sponsors LG Chem
- 11 Apr 2018 Status changed from active, no longer recruiting to completed.
- 24 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 07 Jul 2017 New trial record